Amanote Research
Register
Sign In
Drotrecogin Alfa in Patients With Severe Sepsis: Experience From a Tertiary Care Center in North India
Critical Care
- United Kingdom
doi 10.1186/cc5223
Full Text
Open PDF
Abstract
Available in
full text
Categories
Critical Care
Intensive Care Medicine
Date
January 1, 2007
Authors
R Chawla
S Kansal
A Lall
M Kanwar
D Rosha
A Bansal
V Sikri
Publisher
Springer Science and Business Media LLC
Related search
Clinical Profile of Patients Presenting With Dysphagia ‐ an Experience From a Tertiary Care Center in North India
JGH Open
Hepatology
Gastroenterology
Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)
Critical Care
Critical Care
Intensive Care Medicine
Drotrecogin Alfa Activated as a Treatment for Severe Sepsis in Pediatric Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Drotrecogin Alfa (Activated) May Attenuate Severe Sepsis-Associated Encephalopathy in Clinical Septic Shock
Critical Care
Critical Care
Intensive Care Medicine
Antimicrobial Resistance in Pediatric Sepsis: A Study From a Tertiary Care Hospital in North India
International Journal of Current Research and Academic Review
Incidental Papillary Thyroid Microcarcinoma: Experience From a Tertiary Care Center in South India
International Journal of Contemporary Medical Research [IJCMR]
Recurrent Aphthous Ulcers: Experience From a Tertiary Care Center
Journal of Dental and Maxillofacial Surgery
Patients’ Perception of Quality of Nursing Care; A Tertiary Center Experience From Ethiopia
BMC Nursing
Nursing
Severe P. Falciparum Malaria in Children in a Tertiary Care Center of Allahabad Region of India.
The Internet Journal of Pediatrics and Neonatology
